Pietro Bubba Bello

Graduated in Pharmacy from the University of Perugia and the School of Pharmacy in London. He began his career at Advanced Accelerator Applications, a leading pharmaceutical company in the field of radiopharmaceuticals, which later became a Novartis Company in 2018, holding several positions of responsibility and managing different production sites in Italy and America. With more than 15 years of experience in the pharmaceutical industry, he contributes to obtaining FDA and EMA approved drug approvals. He currently serves as VP Manufacturing & Operations at BetaGlue Therapeutics, an innovative start-up operating in the medical device field.


Accetta Rifiuta